Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Revenue Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year revenue growth rate
Latest
27.28%
↑ 54% above average
Average (9y)
17.76%
Historical baseline
Range
High:78.21%
Low:-52.17%
CAGR
+10.1%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 27.28% |
| 2023 | -33.09% |
| 2022 | -18.75% |
| 2021 | 47.68% |
| 2020 | 35.98% |
| 2019 | -52.17% |
| 2018 | 78.21% |
| 2017 | 29.48% |
| 2016 | 51.53% |
| 2015 | 11.43% |